Anti-tumor activity of lipophilic imidazolium salts on select NSCLC cell lines

被引:30
|
作者
Wright, Brian D. [1 ]
Deblock, Michael C. [1 ]
Wagers, Patrick O. [1 ]
Duah, Ernest [1 ]
Robishaw, Nikki K. [1 ]
Shelton, Kerri L. [1 ]
Southerland, Marie R. [1 ]
DeBord, Michael A. [1 ]
Kersten, Kortney M. [1 ]
McDonald, Lucas J. [1 ]
Stiel, Jason A. [1 ]
Panzner, Matthew J. [1 ]
Tessier, Claire A. [1 ]
Paruchuri, Sailaja [1 ]
Youngs, Wiley J. [1 ]
机构
[1] Univ Akron, Dept Chem, Akron, OH 44325 USA
基金
美国国家科学基金会; 美国国家卫生研究院;
关键词
Imidazolium cation; Imidazolium salt; Anti-tumor; Anticancer; Apoptosis; SILVER CARBENE COMPLEXES; STRUCTURAL CHARACTERIZATION; CISPLATIN;
D O I
10.1007/s00044-015-1330-z
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The anti-tumor activity of imidazolium salts is highly dependent upon the substituents on the nitrogen atoms of the imidazolium cation. We have synthesized and characterized a series of naphthalene-substituted imidazolium salts and tested them against a variety of non-small-cell lung cancer cell lines. Several of these complexes displayed anticancer activity comparable to cisplatin. These compounds induced apoptosis in the NCI-H460 cell line as determined by Annexin V staining, caspase-3, and PARP cleavage. These results strongly suggest that this class of compounds can serve as potent chemotherapeutic agents.
引用
收藏
页码:2838 / 2861
页数:24
相关论文
共 50 条
  • [21] The anti-malarial activity of bivalent imidazolium salts
    Vlahakis, Jason Z.
    Mitu, Simona
    Roman, Gheorghe
    Rodriguez, E. Patricia
    Crandall, Ian E.
    Szarek, Walter A.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (21) : 6525 - 6542
  • [22] Anti-tumor effect of vesnarinone on human hepatocellular carcinoma cell lines
    Kubo, K
    Matuzaki, Y
    Kato, A
    Terai, S
    Okita, K
    GASTROENTEROLOGY, 1997, 112 (04) : A1309 - A1309
  • [23] Anti-tumor potential of high salt in breast Cancer cell lines
    Sharma, Manoj
    Dey, Upalabdha
    Das, Anindhya Sundar
    Olymon, Kaushika
    Kumar, Aditya
    Mukhopadhyay, Rupak
    MOLECULAR BIOLOGY REPORTS, 2024, 51 (01)
  • [24] ANTI-TUMOR ACTIVITY OF ISOCHROMANYLTROPOLONES
    YAMATO, M
    ISHIKAWA, T
    ISHIKAWA, S
    HASHIGAKI, K
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1983, 31 (08) : 2952 - 2954
  • [25] ANTI-TUMOR ACTIVITY OF MELANOMYCIN
    TAKITA, H
    TAKAOKA, M
    HATA, T
    JOURNAL OF ANTIBIOTICS, 1960, 13 (03): : 172 - 176
  • [26] ON THE ANTI-TUMOR ACTIVITY OF GALLIUM
    ANGHILERI, LJ
    THOUVENOT, P
    ROBERT, J
    ARCHIV FUR GESCHWULSTFORSCHUNG, 1982, 52 (06): : 479 - 480
  • [27] ANTI-TUMOR ACTIVITY OF KIJANIMICIN
    BRADNER, WT
    CLARIDGE, CA
    HUFTALEN, JB
    JOURNAL OF ANTIBIOTICS, 1983, 36 (08): : 1078 - 1079
  • [28] ANTI-TUMOR ACTIVITY OF PRUMYCIN
    OKUBO, S
    NAKAMURA, N
    ITO, K
    MARUMO, H
    TANAKA, M
    OMURA, S
    JOURNAL OF ANTIBIOTICS, 1979, 32 (04): : 347 - 354
  • [29] ANTI-TUMOR ACTIVITY OF BENZALDEHYDE
    KOCHI, M
    TAKEUCHI, S
    MIZUTANI, T
    MOCHIZUKI, K
    MATSUMOTO, Y
    SAITO, Y
    CANCER TREATMENT REPORTS, 1980, 64 (01): : 21 - 23
  • [30] ANTI-TUMOR ACTIVITY OF GLUCAGON
    JOHNSON, IS
    WRIGHT, HF
    CANCER RESEARCH, 1959, 19 (05) : 557 - 560